ABBV
Abbvie Inc
Price:  
143.41 
USD
Volume:  
4,658,764.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

Abbvie EV/EBITDA

57.8%
Upside

As of 2023-12-03, the EV/EBITDA ratio of Abbvie Inc (ABBV) is 9.83. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. Abbvie's latest enterprise value is 300,655.10 mil USD. Abbvie's TTM EBITDA according to its financial statements is 30,600.00 mil USD. Dividing these 2 quantities gives us the above Abbvie EV/EBITDA ratio.

Range Selected
Trailing P/E multiples 15.4x - 22.1x 18.0x
Forward P/E multiples 18.0x - 28.0x 21.4x
Fair Price 138.13 - 356.85 226.31
Upside -3.7% - 148.8% 57.8%
143.41 USD
Stock Price
226.31 USD
Fair Price

Abbvie EV/EBITDA - Historical EV/EBITDA Data

Date EV/EBITDA
2023-12-01 38.87
2023-11-30 38.59
2023-11-29 37.54
2023-11-28 37.42
2023-11-27 37.70
2023-11-24 37.58
2023-11-22 37.53
2023-11-21 37.60
2023-11-20 37.49
2023-11-17 37.48
2023-11-16 37.48
2023-11-15 37.29
2023-11-14 37.42
2023-11-13 37.58
2023-11-10 37.56
2023-11-09 37.41
2023-11-08 38.50
2023-11-07 38.53
2023-11-06 38.27
2023-11-03 38.33
2023-11-02 38.83
2023-11-01 38.61
2023-10-31 38.27
2023-10-30 38.46
2023-10-27 37.66
2023-10-26 39.35
2023-10-25 39.37
2023-10-24 39.66
2023-10-23 39.23
2023-10-20 39.63
2023-10-19 39.44
2023-10-18 40.46
2023-10-17 40.43
2023-10-16 39.90
2023-10-13 40.10
2023-10-12 40.19
2023-10-11 40.48
2023-10-10 40.35
2023-10-09 40.41
2023-10-06 40.18
2023-10-05 39.96
2023-10-04 40.03
2023-10-03 39.96
2023-10-02 40.18
2023-09-29 40.40
2023-09-28 41.27
2023-09-27 41.50
2023-09-26 41.72
2023-09-25 41.92
2023-09-22 41.40